Expression of connective tissue growth factor mRNA in the kidney of rats with diabetes mellitus after Hongshen chongcao capsule treatment

Zhao Xian-jun,Zhang Shui-sheng,Li Yan,Jin Xiong-zhen,Song Jing-yu,Gao Sheng-xi

DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.24.022

2008-01-01

Abstract:AIM: To observe the effect and mechanism of Hongshen chongcao capsule on the expression of renal connective tissue growth factor mRNA in rats with diabetes mellitus. METHODS: The experiment was performed at the Laboratory of Pharmacology, and Laboratory of Pathology, Yanbian University Preclinical Medicine College and Institute of Regeneration Medicine of Jilin University from May 2005 to February 2006. Totally 70 Wistar rats of clean grade were selected and randomly divided into normal control group (n=10), model group (n=20), benazepril-treated group (n=20) and traditional Chinese medicine (Hongshen chongcao capsule)-treated group (n=20). Hongshen chongcao capsule was provided by the manufacturing laboratory of Yanbian University Affiliated Hospital, and made by the powder mixture of hongshen and chongcao at certain ratio using milling machine. Rat model of diabetes was established by once intraperitoneal injection of streptozotocin (50 mg/kg). Automatic biochemistry analyser was used to measure the Levels of blood glucose, serum creatinine, urea nitrogen, and urine creatinine at the end of 12 weeks after administration, and the creatinine clearance was calculated. Urinary albumin was quantified using ELISA to calculate urinary albumin excretion rate. Connective tissue growth factor gene expression of renal cortex was measured with reverse transcription-polymerase chain reaction. Levels of renal fibronectin and type Ⅳ collagen protein expression were measured with immunohistochemical method. RESULTS: Fasting blood glucose was significantly higher in the model group than in the model control group (P < 0.01), but was significantly lower in the traditional Chinese medicine-treated group than in the model group and benazepril-treated group (P < 0.01). Levels of urea nitrogen, serum creatinine, creatinine clearance and urinary albumin excretion rate were significantly higher in the model group than in the normal control group (P < 0.01), but significantly lower in the benazepril-treated group and traditional Chinese medicine-treated group than in the model group (P < 0.05-0.01). Expression of connective tissue growth factor mRNA of renal cortex in model group was 3.77 times that of normal control group. The expression of connective tissue growth factor mRNA of benazepril-treated group and traditional Chinese medicine-treated group was significantly decreased by 44.44% and 52.14%, respectively. Fibronectin and type Ⅳ collagen expressions were significantly higher in the model group than in the normal control group (P < 0.01), and those were significantly lower in the benazepril-treated group and traditional Chinese medicine-treated group than in the model group, but higher than normal control group (P < 0.01). CONCLUSION: Hongshen chongcao capsule has protective effect on diabetic nephropathy, which may be correlated with reduce to the deposition of extracellular matrix by down-regulating the expression of connective tissue growth factor mRNA of renal cortex in rats with diabetes mellitus.